horizondiscovery.com

What It Is

Horizon Discovery presents a life-science product portfolio for gene editing and gene regulation, now associated with the Revvity brand. It is not a software developer tool in the traditional sense, but rather a lab-product platform for functional genomics, drug discovery, cancer research, and quality control in genetic testing. Its core offerings include Dharmacon siRNA/CRISPR reagents, engineered cell lines, screening libraries, and Mimix molecular reference standards.

Core Capabilities

In terms of functionality and use cases, the page focuses on CRISPRmod CRISPRa dCas9-VPR Stable Cell Lines. These cells are generated using Horizon’s proprietary CRISPRa dCas9-VPR vector, include a Blasticidin resistance selection marker, and are QC-validated to confirm stable and functional dCas9-VPR expression. The products can be used for single-gene activation experiments, or combined with CRISPRa synthetic crRNA, synthetic sgRNA, lentiviral sgRNA, or predefined/custom screening libraries for larger-scale screening projects. The page also lists cell backgrounds and culture conditions for A549, HCT-116, Jurkat, K-562, RKO, NIH/3T3, HAP1, U2OS, and others.

Ecosystem, Documentation, and Licensing

Its ecosystem strength lies in how tightly the products connect with one another: stable cell lines, guide RNA, screening libraries, the Cherry Pick Custom Library Tool, DharmaFECT transfection reagents, and molecular reference standards together cover the workflow from experimental design to validation. On the documentation side, the page provides cell culture media, supplements, passaging recommendations, experimental support data, quick protocols, and technical manuals, making it fairly practical for lab teams. In terms of licensing, all Horizon engineered cell lines are purchased under a Limited Use Label License, indicating that these are commercial closed-source products and that usage boundaries should be confirmed before procurement.

Pricing and Limitations

The main content does not disclose pricing, payment methods, delivery timelines, or regional distributor information, so value for money can only be assessed cautiously. For experimental teams, the main advantages are a complete product line, relatively clear validation information, and suitability for CRISPRa and functional screening workflows. The drawbacks are limited public procurement information, and the fact that it is not suitable for users looking for APIs, SDKs, CI/CD tools, or code-development tooling.

Who It’s For and Access from China

It is suitable for universities, pharmaceutical companies, CROs, oncology research groups, and genetic testing laboratories conducting gene activation, screening, and QC experiments. Access and payment information for mainland China is not provided in the main content, so its status is unknown. If access or procurement is restricted, alternative or complementary suppliers such as Thermo Fisher Scientific, Synthego, Addgene, IDT, Twist Bioscience, and GenScript may be worth considering.